findmyKOL
Clinical trialNCT00108810CompletedPhase 2Interventional

Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee

SponsorZARS Pharma Inc.Enrollment118Osteoarthritis, KneePain
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Southbay Pharma Research

    Buena Park, California, United States

  • the Center for Rheumatology and Bone Research

    Washington D.C., District of Columbia, United States

  • Radiant Research

    Daytona Beach, Florida, United States

  • University Clinical Research

    Pembroke Pines, Florida, United States

  • Hospital for Special Surgery

    New York, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2005
Primary completion
31 Oct 2005
Completion
31 Oct 2005
Last update posted
5 Jun 2012
Registered enrollment
118
Registry id
NCT00108810

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.